Amy Goundry/LinkedIn
Feb 18, 2026, 12:34
Amy Goundry: Which Are The Next Major Advances in Blood and Plasma-Driven Immune Regulation?
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”The blood–immune interface is a dynamic space where cellular and plasma components regulate immune responses across infection, inflammation, and systemic disease.
At Blood and Plasma we’re particularly interested in rigorous mechanistic research in this area, and we’ve just opened a Special Collection on it.
Which area of immune regulation by blood or plasma components will drive the next major advances?
- Cellular crosstalk – How interactions among erythrocytes, platelets, leukocytes, and endothelium regulate immune activation and resolution
- Plasma-mediated immune modulation – How complement, antibodies, cytokines, metabolites, and extracellular vesicles shape immune cell phenotype and function
- Early biomarkers of dysregulation – Identifying markers that detect immune imbalance early and improve risk stratification and therapeutic targeting
- Inflammation–coagulation links – How immune activation and coagulation pathways intersect in thrombosis, sepsis, and systemic inflammatory disease
Vote — and share what trends you’re seeing in your field!”

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series